Results 441-460 of 1,342 for speaker:James Geoghegan
- Public Accounts Committee: Financial Statements 2023 - Children's Health Ireland
Financial Statements - National Treatment Purchase Fund (3 Jul 2025) James Geoghegan: What does that mean?
- Public Accounts Committee: Financial Statements 2023 - Children's Health Ireland
Financial Statements - National Treatment Purchase Fund (3 Jul 2025) James Geoghegan: Should Ms Hardiman have referred this to the Medical Council? Did that come up in any discussions at the time with the board at the ad hoc meeting?
- Public Accounts Committee: Financial Statements 2023 - Children's Health Ireland
Financial Statements - National Treatment Purchase Fund (3 Jul 2025) James Geoghegan: How is this possible? This individual was the subject of this review, which we keep being told was a HR review and nothing to do with macro issues and cannot be shared. At the heart of it is an individual, which is a HR issue, and how is it possible that a decision was taken to not refer the individual to the Medical Council?
- Public Accounts Committee: Financial Statements 2023 - Children's Health Ireland
Financial Statements - National Treatment Purchase Fund (3 Jul 2025) James Geoghegan: The new CEO decided three years later this is an issue that should be referred to the Medical Council.
- Public Accounts Committee: Financial Statements 2023 - Children's Health Ireland
Financial Statements - National Treatment Purchase Fund (3 Jul 2025) James Geoghegan: I am right. That is why she referred it.
- Public Accounts Committee: Financial Statements 2023 - Children's Health Ireland
Financial Statements - National Treatment Purchase Fund (3 Jul 2025) James Geoghegan: Everyone accepted that Ms Hardiman had a contract of indefinite duration. What then was the dispute about?
- Public Accounts Committee: Financial Statements 2023 - Children's Health Ireland
Financial Statements - National Treatment Purchase Fund (3 Jul 2025) James Geoghegan: Why did it cost €120,000 to work out what the agreement was? Was it accepted that Ms Hardiman was entitled to the salary as a CEO? Was there a factual dispute and, if so, what was that factual dispute?
- Public Accounts Committee: Financial Statements 2023 - Children's Health Ireland
Financial Statements - National Treatment Purchase Fund (3 Jul 2025) James Geoghegan: However, Ms Hardiman can see why people watching or listening are trying to work out why that cost €120,000. Why did she need so many lawyers? If everyone was in agreement that she had a contract of indefinite duration and she was entitled to the CEO salary of an equivalent scale, what was going on in those rooms that it took €120,000 to resolve?
- Public Accounts Committee: Financial Statements 2023 - Children's Health Ireland
Financial Statements - National Treatment Purchase Fund (3 Jul 2025) James Geoghegan: That is fair. Ms Hardiman said she would be happy to waive her NDA. Am I correct in that?
- Public Accounts Committee: Financial Statements 2023 - Children's Health Ireland
Financial Statements - National Treatment Purchase Fund (3 Jul 2025) James Geoghegan: Would Ms Nugent be happy for CHI to waive the NDA in relation to this process?
- Public Accounts Committee: Financial Statements 2023 - Children's Health Ireland
Financial Statements - National Treatment Purchase Fund (3 Jul 2025) James Geoghegan: Is that a matter she could raise with the board?
- Public Accounts Committee: Financial Statements 2023 - Children's Health Ireland
Financial Statements - National Treatment Purchase Fund (3 Jul 2025) James Geoghegan: Which is the third entity? Is it the HSE? Ms Hardiman said there were three parties to this NDA.
- Public Accounts Committee: Financial Statements 2023 - Children's Health Ireland
Financial Statements - National Treatment Purchase Fund (3 Jul 2025) James Geoghegan: Which Department?
- Public Accounts Committee: Financial Statements 2023 - Children's Health Ireland
Financial Statements - National Treatment Purchase Fund (3 Jul 2025) James Geoghegan: Perhaps we can go back to the Department of Health. Who requested the NDA? Was it Ms Hardiman, the Department of Health or CHI?
- Public Accounts Committee: Financial Statements 2023 - Children's Health Ireland
Financial Statements - National Treatment Purchase Fund (3 Jul 2025) James Geoghegan: Who initiated the NDA?
- Public Accounts Committee: Financial Statements 2023 - Children's Health Ireland
Financial Statements - National Treatment Purchase Fund (3 Jul 2025) James Geoghegan: No, who requested that there be an NDA? Was it Ms Hardiman, the Department of Health or CHI?
- Public Accounts Committee: Financial Statements 2023 - Children's Health Ireland
Financial Statements - National Treatment Purchase Fund (3 Jul 2025) James Geoghegan: I know that. I am just asking about the NDA.
- Public Accounts Committee: Financial Statements 2023 - Children's Health Ireland
Financial Statements - National Treatment Purchase Fund (3 Jul 2025) James Geoghegan: However, there is an NDA dealing with the whole outworkings of it as well, whereby Ms Hardiman could not discuss what had taken place or what had been agreed.
- Public Accounts Committee: Financial Statements 2023 - Children's Health Ireland
Financial Statements - National Treatment Purchase Fund (3 Jul 2025) James Geoghegan: Please do. I will get my time back from the Chair, I am sure.
- Public Accounts Committee: Financial Statements 2023 - Children's Health Ireland
Financial Statements - National Treatment Purchase Fund (3 Jul 2025) James Geoghegan: How does that relate then to the code of practice for the governance of State bodies that we have highlighted in terms of not having NDAs?